N-hydroxy-3-{4-[2-(2-methyl-1H-indol-3-yl)-ethylsulfamoyl]-phenyl}-acrylamide

ID: ALA3329991

PubChem CID: 118712701

Max Phase: Preclinical

Molecular Formula: C20H21N3O4S

Molecular Weight: 399.47

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1[nH]c2ccccc2c1CCNS(=O)(=O)c1ccc(/C=C/C(=O)NO)cc1

Standard InChI:  InChI=1S/C20H21N3O4S/c1-14-17(18-4-2-3-5-19(18)22-14)12-13-21-28(26,27)16-9-6-15(7-10-16)8-11-20(24)23-25/h2-11,21-22,25H,12-13H2,1H3,(H,23,24)/b11-8+

Standard InChI Key:  JMDMVJXTEMLGRO-DHZHZOJOSA-N

Molfile:  

     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
    8.7187   -7.7840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4251   -7.3731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1341   -7.7794    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4225   -6.5559    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7135   -6.1496    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0097   -7.3777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3033   -7.7885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5800   -9.7072    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1755   -9.0015    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.7666   -9.7046    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0058   -8.3190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2493   -9.0989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3412   -7.8794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5421   -7.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5977   -8.6610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0476   -9.2685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4554   -9.9795    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2576   -9.8113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3455   -8.9965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8634  -10.3598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0543   -8.5898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7609   -9.0004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4697   -8.5937    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8851   -8.5976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5904   -9.0093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2987   -8.6033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5899   -7.3749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8844   -7.7832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  1  6  2  0
  6  7  1  0
  9  8  2  0
 10  9  2  0
 11 12  2  0
 12 16  1  0
 15 13  1  0
 13 14  2  0
 14 11  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 15  1  0
 18 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23  9  1  0
  9 24  1  0
 24 25  2  0
 25 26  1  0
 26  7  2  0
  7 27  1  0
 27 28  2  0
 28 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3329991

    ---

Associated Targets(Human)

HDAC1 Tclin Histone deacetylase (6747 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC3 Tclin Histone deacetylase 3 (3654 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC1 Tclin Histone deacetylase 1 (10854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC2 Tclin Histone deacetylase 2 (3971 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC6 Tclin Histone deacetylase 6 (20808 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ASPC1 (1310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rela Transcription factor p65 (175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 399.47Molecular Weight (Monoisotopic): 399.1253AlogP: 2.52#Rotatable Bonds: 7
Polar Surface Area: 111.29Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 9.47CX Basic pKa: CX LogP: 2.47CX LogD: 2.46
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.28Np Likeness Score: -0.83

References

1. Mehndiratta S, Hsieh YL, Liu YM, Wang AW, Lee HY, Liang LY, Kumar S, Teng CM, Yang CR, Liou JP..  (2014)  Indole-3-ethylsulfamoylphenylacrylamides: potent histone deacetylase inhibitors with anti-inflammatory activity.,  85  [PMID:25113875] [10.1016/j.ejmech.2014.08.020]
2. Liu W, Liang Y, Si X..  (2020)  Hydroxamic acid hybrids as the potential anticancer agents: An Overview.,  205  [PMID:32791404] [10.1016/j.ejmech.2020.112679]

Source